Key Highlights
- Federal safety probe into 2023 Model Y steering components concluded with no recall needed
- Shares down 16% in 2026, trading at $378.67 at Tuesday’s open
- First quarter earnings per share exceeded forecasts ($0.41 actual vs $0.39 projected), revenue fell short at $22.39B against $22.96B consensus
- Aggressive $25B capital expenditure strategy for 2026 may result in negative free cash flow
- Delayed timelines for robotaxi expansion and Optimus robot deployment maintain investor caution
Tesla (TSLA) secured a regulatory clearance on Tuesday, though the development failed to generate significant market enthusiasm.
The National Highway Traffic Safety Administration concluded its review of potentially loose steering wheel fasteners affecting approximately 120,000 Model Y vehicles from 2023, determining no safety defect existed and eliminating the need for a formal recall. Market response proved muted, with shares gaining just 0.4% in morning trading before retreating.
TSLA started Tuesday’s session at $378.67, reflecting a 16% decline year-to-date. The broader S&P 500 index declined 0.5% during the same session.
Recall investigations typically generate minimal impact on Tesla’s share performance. While the federal probe represented a potential concern, its resolution without action provided limited upside catalyst for shareholders.
The primary narrative centers on Tesla’s first quarter financial results, disclosed April 22nd. Per-share earnings reached $0.41, surpassing the $0.39 analyst consensus. Total revenue registered $22.39 billion, falling below the anticipated $22.96 billion. Revenue climbed 15.8% compared to the prior year period.
Physical AI Development Trailing Projections
The revenue shortfall alone didn’t trigger substantial selling pressure. Instead, market sentiment reflects concerns about Tesla’s advancement in what management terms “physical AI” — autonomous taxi services and the Optimus robotic platform.
Tesla initiated its autonomous taxi operations in Austin, Texas during June, yet geographic expansion to additional markets has progressed slower than market participants anticipated. Deployment schedules for Optimus have similarly extended beyond original projections.
Deutsche Bank’s Edison Yu addressed the situation candidly Monday: “Scaling physical AI ain’t easy.” Yu maintains a Buy recommendation with a $465 valuation target.
Yu noted that while capital spending increases related to chip technology and solar operations were properly communicated, generating upward stock momentum would prove challenging “until some of these major physical AI efforts show meaningful progress on the commercial/operational front.”
Tesla has outlined a $25 billion capital investment program for 2026. Spending at this magnitude is projected to drive free cash flow into negative territory for the year, creating investor anxiety when initially announced.
Wall Street Opinions Remain Mixed
Analyst sentiment on Tesla remains fragmented. Recent price objectives span from $220 to $428. The mean analyst target registers at $398.42, with the aggregate rating at Hold. Among 41 tracked analysts, 19 recommend Buy, 16 suggest Hold, and 6 advise Sell.
Cantor Fitzgerald maintained its Overweight stance with a $510 objective. Canaccord elevated its target from $420 to $450 while keeping a Buy rating. BNP Paribas raised its position from Underperform to Neutral. HSBC launched coverage with a Buy recommendation.
Wealthfront Advisers acquired 14,419 shares during the fourth quarter, expanding its holdings to 408,545 shares, representing approximately $183.7 million in value. Institutional stakeholders control 66.2% of outstanding shares.
Regarding insider transactions, Chief Financial Officer Vaibhav Taneja divested 2,264 shares in March at $397.03 per share. Board member Kathleen Wilson-Thompson sold 25,809 shares at $359.33 in late March. Company insiders have collectively sold 53,804 shares valued at over $20.8 million during the most recent quarter.
Tesla’s 50-day moving average currently sits at $385.16. The 200-day moving average stands at $420.14. The stock’s 52-week trading range extends from $270.78 to $498.83.


